Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection (Q42254406)

19 October 2017

title

Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection (English)

1 reference

19 October 2017

1 reference

1 reference

hepatocellular carcinoma

1 reference

Ji-Cai Zhang

1 reference

19 October 2017

Bo Gao

1 reference

19 October 2017

Zong-Tao Yu

1 reference

19 October 2017

Xiao-Bo Liu

1 reference

19 October 2017

Jun Lu

1 reference

19 October 2017

Fei Xie

1 reference

19 October 2017

Hai-Jun Luo

1 reference

19 October 2017

Hai-Ping Li

1 reference

19 October 2017

publication date

20 November 2013

1 reference

19 October 2017

1 reference

19 October 2017

1 reference

19 October 2017

1 reference

19 October 2017

page(s)

2795-2802

1 reference

Hepatocellular carcinoma (HCC) in a patient with hepatitis B virus (HBV) infection

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Impact of Hepatitis B Virus (HBV) X Gene Mutations on Hepatocellular Carcinoma Development in Chronic HBV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Hepatitis B virus: pathogenesis, viral intermediates, and viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Immunohistochemical determination of the P15 protein expression in cutaneous squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Inverse association of p16 INK4a and p14 ARF methylation of the CDKN2a locus in different Gleason scores of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Synergism between DNA methylation and macroH2A1 occupancy in epigenetic silencing of the tumor suppressor gene p16(CDKN2A)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Infrequent mutations and no methylation of CDKN2A (p16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Methylation and expression analysis of tumor suppressor genes p15 and p16 in benzene poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Correlation of telomere length shortening with promoter methylation profile of p16/Rb and p53/p21 pathways in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Arginine methylation of human adenovirus type 5 L4 100-kilodalton protein is required for efficient virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1372-0

Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients

21 January 2018

1 reference

12 December 2020

p16 is a major inactivation target in hepatocellular carcinoma

1 reference

12 December 2020

EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1

1 reference

12 December 2020

Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.

1 reference

12 December 2020

Silence of p15 expression by RNAi enhances cisplatin resistance in hepatocellular carcinoma cells

1 reference

12 December 2020

p16(INK4a) and p15(INK4b) gene promoter methylation in cervical cancer patients.

1 reference

12 December 2020

[Methylation and expression analysis of p16(INK4a) and RB genes in meningiomas].

1 reference

12 December 2020

10.1007/S13277-013-1372-0

Identifiers

DOI

1 reference

Dimensions Publication ID

19 October 2017

1031501455

0 references

1 reference